Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.

Source:http://linkedlifedata.com/resource/pubmed/id/10100701

Download in:

View as

General Info

PMID
10100701